Hashimoto’s disease is not fatal for the vast majority of people who have it. With proper treatment, most people with Hashimoto’s live a normal lifespan. However, if left completely untreated for years, the resulting hypothyroidism can damage the heart, raise cholesterol, and in rare cases lead to a life-threatening emergency called myxedema coma. The disease itself doesn’t directly kill, but the complications of ignoring it can.
How Hashimoto’s Affects Mortality Risk
A meta-analysis covering more than 1.1 million older adults found that people aged 60 and older with hypothyroidism were 26 percent more likely to die from all causes compared to people without the condition. That sounds alarming, but context matters. The increased risk applied mainly to people with more significant, undertreated thyroid dysfunction. Those with milder forms of thyroid disease showed no increased mortality. And among people 80 and older, the risk difference disappeared entirely.
In other words, the risk is real but modest, concentrated in a specific age group, and closely tied to whether the condition is being managed. Hashimoto’s that progresses to hypothyroidism and goes untreated for years is what creates danger, not the autoimmune process by itself.
The One True Emergency: Myxedema Coma
The most dangerous complication of long-standing, untreated hypothyroidism is myxedema coma. This is a medical emergency where the body’s functions slow so dramatically that organs begin to fail. Body temperature drops, breathing slows, and the brain can become dangerously impaired. Nearly 30 percent of patients hospitalized with myxedema coma die.
Myxedema coma is rare. It occurs most often in elderly patients during winter months and is typically triggered by an additional stressor like an infection, a heart attack, or surgery. It almost never happens to someone who is taking thyroid medication and getting regular blood work. This is the scenario people fear when they ask whether Hashimoto’s can be fatal, and it’s largely preventable.
Heart Disease and Cardiovascular Risk
The more common long-term concern with untreated Hashimoto’s isn’t a sudden crisis. It’s a slow increase in cardiovascular risk. Hypothyroidism raises LDL cholesterol, contributes to high blood pressure, and can eventually lead to heart disease and heart failure. These effects build up over years when thyroid levels remain low.
Research on cardiovascular outcomes has produced somewhat mixed results. Some studies show a higher heart attack risk in people with even mildly low thyroid function, while others find no significant difference in cardiovascular death rates between people with subclinical hypothyroidism and those with normal thyroid function. The takeaway is that cardiovascular risk from Hashimoto’s is not dramatic in people whose condition is monitored, but it’s a real concern if thyroid hormone levels drift low and stay there.
A Small Risk of Thyroid Lymphoma
One lesser-known risk is thyroid lymphoma, a rare cancer that develops in thyroid tissue. People with Hashimoto’s have a 67-fold higher risk of this cancer compared to people with other benign thyroid conditions. That relative number sounds frightening, but the absolute risk is very low: only about 0.5 percent of all Hashimoto’s patients ever develop thyroid lymphoma. The risk is highest in people who have had Hashimoto’s for decades. A rapidly growing lump in the thyroid, especially in someone with long-standing Hashimoto’s, warrants prompt evaluation.
Other Autoimmune Conditions
Hashimoto’s is an autoimmune disease, and having one autoimmune condition raises the odds of developing others. About 14 percent of people with Hashimoto’s develop at least one additional autoimmune disorder. Rheumatoid arthritis is the most common, affecting roughly 4 percent. The risk is more than 10 times higher for conditions like pernicious anemia (a vitamin B12 absorption problem), lupus, Addison’s disease (adrenal insufficiency), celiac disease, and vitiligo.
None of these are inevitable, but they’re worth being aware of. Symptoms that seem unrelated to your thyroid, like unexplained fatigue beyond what hypothyroidism explains, joint pain, digestive problems, or unusual skin changes, may point to a second autoimmune process.
Does Treatment Change Survival?
This is where the data gets nuanced. For people under 65 with subclinical hypothyroidism (mildly elevated TSH but few or no symptoms), treatment with thyroid hormone replacement was associated with 37 percent lower mortality compared to no treatment. For people over 65, treatment didn’t show a clear survival benefit in studies, though it can still improve quality of life by relieving symptoms like fatigue, weight gain, and cognitive sluggishness.
The lack of a dramatic mortality benefit from medication in older adults doesn’t mean treatment is pointless. It likely reflects the fact that mild hypothyroidism in elderly patients carries less additional risk than it does in younger people, and that treatment decisions at that age involve balancing multiple health factors. For younger and middle-aged adults, the evidence supports a meaningful protective effect from keeping thyroid levels in range.
What Untreated Hashimoto’s Does Over Time
Hashimoto’s disease is progressive. The immune system gradually destroys thyroid tissue, and the gland produces less and less hormone over months to years. Some people plateau at a mildly underactive thyroid and stay there. Others progress to full-blown hypothyroidism that requires lifelong medication.
Left untreated, the downstream effects accumulate. High cholesterol hardens arteries. The heart works harder to compensate for a sluggish metabolism. Fluid can build up around the heart. Mental sharpness declines. In pregnancy, untreated hypothyroidism raises the risk of miscarriage, preeclampsia, and developmental problems in the baby. None of these outcomes are guaranteed, but they represent the real cost of leaving Hashimoto’s unmanaged for years.
The bottom line is straightforward: Hashimoto’s disease is highly manageable and rarely fatal. The people who run into serious trouble are those who go undiagnosed for a long time or stop taking their medication. A simple blood test and, when needed, a daily pill are enough to neutralize most of the risk.